| Literature DB >> 17638129 |
A Zohmann1, R Hawel, G Klein, W Kullich, G Lötsch.
Abstract
S(+)-ibuprofen (dexibuprofen) is an NSAID offering a lot of advantages in the treatment of rheumatism and pain. A randomized double-blind, parallel group study in 110 patients showed equivalence in efficacy of 900 mg dexibuprofen (Seractil 300 mg, Gebro Fieberbrunn, Austria) vs. 150 mg diclofenac sodium. Regarding tolerance there was a trend to superiority of dexibuprofen. Therefore dexibuprofen can be characterized as an effective and very tolerable drug against inflammation and pain.Entities:
Year: 1998 PMID: 17638129 DOI: 10.1007/s10787-998-0008-2
Source DB: PubMed Journal: Inflammopharmacology ISSN: 0925-4692 Impact factor: 5.093